Dear Users,

The journal ratings for SCImago Journal & Country Rank 2025 have been published.

https://www.scimagojr.com/

Zöld Éva

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2003-2026

2026

Mogyoróssy, S., Griger, Z., Tarr, T., Zöld, É., Pfliegler, G., Brúgós, B., Nagy, G., Mangel, K. Z., Kumánovics, G., Bakai, R., Kovács, L., Rideg, A., Nagy, E., Farkas, O., Nagy, G., Antal-Szalmás, P., Szűcs, G., Szamosi, S., Szekanecz, Z., Rákóczi, É., Bodoki, L.: Management and Prognosis of Anti-MDA5 Dermatomyositis: Insights from a National Multicenter Cohort.
Biomedicines. 14 (3), 1-14, (article identifier: 709), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

Q1 Medicine (miscellaneous) (2025)

2025

Tóthfalusi, D., Gulyás, A., Koncz, A., Zöld, É., Illés, Á., Miltényi, Z.: Hodgkin Lymphoma Associated with Common Variable Immunodeficiency: the Role of Early Diagnosis and Multidisciplinary Management.
Hematol Rep. 17 (6), 1-15, (article identifier: 65), 2025.

doi DEA

Journal metrics:

Q3 Hematology

2024

Feketéné Posta, E., Fekete, I., Gyarmati, É., Stündl, L., Zöld, É., Barta, Z.: The Effects of Artificial Sweeteners on Intestinal Nutrient-Sensing Receptors: Dr. Jekyll or Mr. Hyde?.
Life (Basel). 14 (1), 1-21, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Ecology, Evolution, Behavior and Systematics

Q1 Paleontology

Q2 Space and Planetary Science

Feketéné Posta, E., Fekete, I., Várkonyi, I., Zöld, É., Barta, Z.: The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.
Cells. 13 (20), 1-31, (article identifier: 1688), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

2023

Fedor, I., Zöld, É., Barta, Z.: Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel Diseases.
Life (Basel). 13 (3), 1-12, (article identifier: 652), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Ecology, Evolution, Behavior and Systematics

Q1 Paleontology

Q2 Space and Planetary Science

2022

Zöld, É.: COVID-19 betegség és immunhiány.
Focus Med. 24 (2), 24-28, 2022.

DEA

Fedor, I., Gyarmati, É., Zöld, É., Barta, Z.: Gondolatok a cink szerepéről az immunrendszerünkben.
Orvostovábbk. szle. 29 (10), 83-89, 2022.

DEA

Fedor, I., Zöld, É., Barta, Z.: Liver Abnormalities in Turner Syndrome: the Importance of Estrogen Replacement.
J. Endocr. Soc. 6 (10), 1-7, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Endocrinology, Diabetes and Metabolism

Fedor, I., Zöld, É., Barta, Z.: Microscopic colitis in older adults: impact, diagnosis, and management.
Ther. Adv. Chronic Dis. 13, 1-15, (article identifier: 20406223221102821), 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

2021

10.

Fedor, I., Zöld, É., Barta, Z.: Microscopic colitis: controversies in clinical symptoms and autoimmune comorbidities.
Ann. Med. 53 (1), 1279-1284, 2021.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

11.

Fedor, I., Zöld, É., Barta, Z.: Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.
J Clin Med. 10 (24), 1-13, (article identifier: 5984), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

2019

12.

Fedor, I., Zöld, É., Barta, Z.: A gluténérzékenység extraintestinalis spektruma.
Orv. hetil. 160 (34), 1327-1334, 2019.

doi DEA WoS Scopus

Journal metrics:

Q3 Medicine (miscellaneous)

13.

Czompa, L., Barta, Z., Ziad, H., Németh, G., Rentka, A., Zakarné Aszalós, Z., Zöld, É., Gesztelyi, R., Zsuga, J., Szodoray, P., Kemény-Beke, Á.: Corneal Manifestations of Inflammatory Bowel Disease.
Semin Ophthalmol. 34 (7-8), 543-550, 2019.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Ophthalmology

14.

Barta, Z., Czompa, L., Rentka, A., Zöld, É., Gálné Remenyik, J., Biró, A., Gesztelyi, R., Zsuga, J., Szodoray, P., Kemény-Beke, Á.: Evaluation of objective signs and subjective symptoms of dry eye disease in patients with inflammatory bowel disease.
Biomed. Res. Int. 2019, 1-9, (article identifier: 8310583), 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Immunology and Microbiology (miscellaneous)

Q2 Medicine (miscellaneous)

15.

Fedor, I., Zöld, É., Barta, Z.: Food-specific IgG Antibodies in Crohn's Disease: what Came First, the Chicken or the Egg?.
Intern. Med. 58 (19), 2123, 2019.

doi DEA

16.

Zöld, É., Barta, Z., Török, M., Soltész, P., Szegedi, A., Sipka, S.: Staphylococcus által kiváltott, immunglobulin-E-alapú anafilaxiás reakciók Crohn-betegségben: egy tünetegyüttes első leírása.
Orv. hetil. 160 (38), 1514-1518, 2019.

doi DEA WoS Scopus

Journal metrics:

Q3 Medicine (miscellaneous)

2017

17.

Zöld, É.: A D-vitamin immunmoduláns hatásai.
Focus Med. 19 (1), 15-19, 2017.

DEA

2016

18.

Papp, G., Gyimesi, E., Szabó, K., Zöld, É., Zeher, M.: Increased IL-21 Expression Induces Granzyme B in Peripheral CD5+ B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren's Syndrome.
Mediat. Inflamm. 2016, 1-8, 2016.

doi DEA

Journal metrics:

Q2 Cell Biology

Q2 Immunology

2015

19.

Papp, G., Gyimesi, E., Szabó, K., Zöld, É., Zeher, M.: Analysis of Naive, Memory and Granzyme B Expressing Peripheral B Cell Subsets in Sjo?gren's Syndrome.
Scand. J. Immunol. 81, 378-379, 2015.

DEA

20.

Bodolay, E., Szodoray, P., Végh, J., Soltész, P., Csípő, I., Zöld, É., Dezső, B., Baráth, S., Hajas, Á. H.: Kórlefolyás és túlélés kevert kötőszöveti betegségben 2015-ben.
Immunol. Szle. 7 (2), 21-31, 2015.

DEA

2014

21.

Bodolay, E., Prohászka, Z., Paragh, G., Csípő, I., Nagy, G., Laczik, R., Demeter, N., Zöld, É., Nakken, B., Szegedi, G., Szodoray, P.: Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.
Immunol. Res. 60, 50-59, 2014.

doi DEA

Journal metrics:

Q1 Immunology

22.

Zöld, É., Bodolay, E., Dezső, B., Soós, G., Nakken, B., Szodoray, P.: Mixed connective tissue disease associated with autoimmune hepatitis and pulmonary fibrosis.
Isr. Med. Assoc. J. 16, 733-734, 2014.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

23.

Zöld, É., Horváth, I. F., Tarján, P., Barta, Z., Zeher, M.: Polyneuropathiaként jelentkező mikroszkópos polyangiitis esete.
LAM 24 (8-9), 427-432, 2014.

DEA

Journal metrics:

Q4 Medicine (miscellaneous)

2013

24.

Hajas, Á. H., Szodoray, P., Nakken, B., Gaál, J., Zöld, É., Laczik, R., Demeter, N., Nagy, G., Szekanecz, Z., Zeher, M., Szegedi, G., Bodolay, E.: Clinical course, prognosis, and causes of death in mixed connective tissue disease.
J. Rheumatol. 40 (7), 1134-1142, 2013.

doi DEA WoS Scopus

Journal metrics:

Q2 Immunology

Q1 Immunology and Allergy

Q1 Rheumatology

25.

Baráth, S., Nagy, G., Zöld, É., Csípő, I., Gyimesi, E., Zeher, M., Bodolay, E.: Conductor of regulatory cells: does vitamin D restore the shifted balance of the distinct regulatory cell types in undifferentiated connective tissue disease?.
Immunol. Lett. 153 (1-2), 71-72, 2013.

doi DEA

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy